The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)


Barnett A. H. , Krentz A. J. , Strojek K., Sieradzki J., Azizi F., Embong M., ...More

DIABETES OBESITY & METABOLISM, vol.10, no.12, pp.1239-1247, 2008 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 12
  • Publication Date: 2008
  • Doi Number: 10.1111/j.1463-1326.2008.00894.x
  • Journal Name: DIABETES OBESITY & METABOLISM
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.1239-1247

Abstract

Aim: To determine if therapeutic management programmes for type 2 diabetes that include self-monitoring of blood glucose (SMBG) result in greater reductions in glycated haemoglobin (HbA1c) compared with programmes without SMBG in non-insulin requiring patients.